Subscribe To

Price Alert Latest News Economic Calendar News

MDAI / Spectral AI expands diabetic foot ulcer study to additional clinical sites

Spectral AI Inc (NASDAQ:MDAI) announced it has added seven clinical sites to its multi-centre study of its DeepView Wound Imaging System for diabetic foot ulcers. The company said that its proprietary technology uses multi-spectral imaging and artificial intelligence (AI) to provide clinicians with a healing assessment of diabetic foot ulcers, leading to more accurate and timely diagnosis and therapeutic intervention. Read More

Demo Live Account See Partner Details

Content Topics

Spectral

Expands

Diabetic

Foot

Ulcer

Study

Additional

Clinical

Stock

MDAI

Posted: Oct 16 2023, 08:45

Author Name: Proactive Investors

MDAI News

By Proactive Investors
October 24, 2023

Spectral AI taps Paul Chadwick to lead DeepView global expansion

Spectral AI Inc (NASDAQ:MDAI) is beefing up its executive team in the UK with the addition of Prof Paul Chadwick. Chadwick, a distinguished clinical s

By Proactive Investors
October 23, 2023

Spectral AI provides positive 2023 and 2024 revenue guidance

Spectral AI Inc (NASDAQ:MDAI) has announced that its full-year 2023 revenue is expected to approximately $17.4 million, while its revenue in 2024 is e

By Proactive Investors
October 19, 2023

Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK

Spectral AI Inc (NASDAQ:MDAI) shares surged in pre-market trade after the company announced that its DeepView SnapShot Wound Imaging System is now Un

By Proactive Investors
October 16, 2023

Spectral AI expands diabetic foot ulcer study to additional clinical sites

Spectral AI Inc (NASDAQ:MDAI) announced it has added seven clinical sites to its multi-centre study of its DeepView Wound Imaging System for diabetic

By PennyStocks
October 4, 2023

Are Penny Stocks Worth It? 4 To Watch With Big News

Penny stocks, defined as stocks trading under $5 per share, are known for their volatility and potential for significant returns. However, the low pri

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.